First TAVR for Aortic Regurgitation Moves to Phase 3 Trial ...Middle East

Medscape - News
The first transcatheter aortic valve replacement device designed specifically to control aortic regurgitation performs well at 2 years in advance of randomized trial, reported investigators. Medscape Medical News

Hence then, the article about first tavr for aortic regurgitation moves to phase 3 trial was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First TAVR for Aortic Regurgitation Moves to Phase 3 Trial )

Apple Storegoogle play

Last updated :

Also on site :